Call Options

11 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $34.8 Million - $40.7 Million
-1,376,400 Reduced 98.2%
25,300 $707,000
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $370,227 - $425,139
-14,300 Reduced 1.01%
1,401,700 $38.9 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $122 Million - $158 Million
-4,670,000 Reduced 76.73%
1,416,000 $40.8 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $151 Million - $176 Million
4,695,000 Added 337.53%
6,086,000 $202 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $50.2 Million - $58.1 Million
1,391,000 New
1,391,000 $51 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $10.7 Million - $15.9 Million
260,000 Added 1300.0%
280,000 $16.5 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $2.87 Million - $3.25 Million
-80,000 Reduced 80.0%
20,000 $783,000
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $157 Million - $200 Million
-4,700,000 Reduced 97.92%
100,000 $3.68 Million
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $79.4 Million - $93.1 Million
2,500,000 Added 108.7%
4,800,000 $176 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $22.6 Million - $27.4 Million
750,000 Added 48.39%
2,300,000 $75.2 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $48.1 Million - $52.9 Million
1,550,000
1,550,000 $55.3 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.